Company · CIK 0001740547
Urovant Sciences Ltd.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Bermuda
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/AUrovant Sciences Ltd.0001193125-21-099584 · 68.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-097522 · 288.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-092665 · 24.9 KBSEC(opens sec.gov)
- SC 13G/AUrovant Sciences Ltd.0001193125-21-044731 · 64.3 KBSEC(opens sec.gov)
- 10-QQuarterly update0001564590-21-005814 · 9.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-21-005780 · 310.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-037406 · 37.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-21-005040 · 90.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-325982 · 50.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-302694 · 39.8 KBSEC(opens sec.gov)
Insiders
- BANSAL AJAYSee Remarks
- Dexcel Pharma Technologies Ltd.See remarks
- Dexxon Holdings Ltd.See remarks
- Ebersole NoriSVP;CHRO/Urovant Sciences, Inc
- Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc.
- HALVORSEN OLE ANDREASFormer 10% Owner
- Hindman James M.Director
- Johnston WaltSee Remarks
- Katkin KeithDirector, PEO;CEO/Urovant Sciences, Inc.
- Kurstjens SefDirector
Tickers
No tickers on record.
Addresses
business
5281 CALIFORNIA AVENUE SUITE 100
IRVINE, CA, 92617
mailing
5281 CALIFORNIA AVENUE SUITE 100
IRVINE, CA, 92617
Same industry